Navigation Links
Shire Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII
Date:11/11/2009

herapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's Web site: http://www.shire.com/.

THE "SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceutical and Human Genetic Therapies products, as well as the ability to secure and integrate new products for commercialization and/or development; government regulation of the Company's products; the Company's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on the Company's products; the Company's ability to register, maintain and enforce patents and other intellectual property rights relating to its products; the Company's ability to obtain and maintain government and other third-party reimbursement for its products; and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission.

SOURCE Shire plc


'/>"/>
SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
2. Shire Continues to Deliver Excellent Growth From Core Products
3. Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
4. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
5. Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA
6. Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
7. Veriscrip and DAMMAD Team Up to Combat Prescription Drug Abuse in New Hampshire
8. New Hampshire Rx Card Launching Statewide
9. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
10. Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
11. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 The Eastern ... Both established medical-device providers as well as new medical-device ... region, while simultaneously looking at ways to reduce the ... Using distributors is one of the effective means to ... devices distribution market in Eastern European and provides profiles ...
(Date:9/30/2014)... 2014 The report based on ... Share, Growth and Forecast, 2007 - 2017," elaborated by ... 20.8 billion in 2012 and is further expected to ... CAGR of 7.3% from 2012 to 2017. ... purposes, especially to prevent chronic diseases that may occur ...
(Date:9/30/2014)... In a recent study it ... of the Eldor spinal needle 25G, 103 mm appeared ... point spinal needles of the same gauge and length ... is an excellent type of regional anesthesia for many ... It is estimated that 100 million patients ...
Breaking Medicine Technology:Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4
... 2011 Actavis Group, an international generic pharmaceuticals company, ... US Food & Drug Administration to market Valacyclovir Hydrochloride ... and 1 gram, the generic equivalent of Valtrex® by ... the 12 months ending December 31, 2010, according to ...
... 2011 NephRx Corporation today announced issuance of a ... factor peptide NX002 as a potential treatment for inflammatory ... have applications in acute and chronic diseases of the ... has been shown to stimulate the growth of epithelial ...
Cached Medicine Technology:Actavis Receives Approval of Valacyclovir Hydrochloride Tablets in the U.S. 2NephRx Corp. Awarded U.S. Patent for Use of Novel Growth Factor Peptide NX002 in Inflammatory Bowel Disease 2
(Date:9/30/2014)... leading cause of allergy-related sudden deaths in the U.S., ... to 2010, conducted by researchers at Montefiore ... Medicine of Yeshiva University . The study, published online ... Immunology , also found that the risk of fatal ... and African-Americans and that such deaths increased significantly in ...
(Date:9/30/2014)... EverStryke , the permanent match currently offered ... with a free book and class all about survival education ... an investigative review. , “Joe Marshall of SurvivalLife.com is ... preparation niche, and this product is an excellent way to ... products that Joe offers on his website to help people ...
(Date:9/30/2014)... 2014 The American Diabetes Association ... diabetics curb their sweet tooth, but the most recent ... September, suggests that zero-calorie sweeteners may actually be linked ... , The Weizmann Institute of Science in Israel ... to mice, the mice developed glucose intolerance. They then ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Hospice ... its annual “In Celebration” gala, honoring three outstanding ... mission of striving to provide extraordinary and dignified ... facing a serious or life-limiting illness. , The ... in Rye, NY and recognized William (Bill) J. ...
(Date:9/30/2014)... 2014 A group of Americans is headed ... epidemic that, left unchecked, could create a catastrophic, global pandemic. ... to Africa. John Rogers, the Executive Director the Eugene Bell ... fight a disease most think mankind conquered long ago: tuberculosis. ... ago is on the comeback in several countries - what’s ...
Breaking Medicine News(10 mins):Health News:Comprehensive Study of allergic deaths in US finds medications are main culprit 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2
... Patricia A. Woertz Appointed to Board of Directors, ... & Gamble,Company (NYSE: PG ) today announced ... chief executive officer of Archer Daniels Midland,Corporation (NYSE: ... directors effective,immediately., (Photo: http://www.newscom.com/cgi-bin/prnh/20080108/CLTU115-a ), ...
... ... Expertise in Healthcare, BROOKFIELD, Wis., Jan. ... company, has added,Shakila Shimp as Director of Client Services for ... provider-side expertise,to the company,s health care industry customers., Shimp ...
... 43 million Americans,suffering from arthritis, hip replacement is ... traditional hip replacement, called hip,resurfacing, is on the ... minimized risk of dislocation and potential benefits related ... (See video from Stryker at:, http://media.medialink.com/WebNR.aspx?story=34296 ) ...
... and "Paperless" Environment ... Make it Among the First of Its Kind, DUBLIN, ... Hospital this morning at 7 a.m. sharp to begin caring ... Methodist, the first new, full-service hospital to be built in,central ...
... TMK ) will release Fourth Quarter 2007 earnings after ... with Torchmark,s,Fourth Quarter 2007 Earnings Release, you are invited ... live over the Internet on Thursday,February 7, 2008 at ... the,Company,s Q4-2007 earnings press release and other financial and,statistical ...
... Statin Use May Be Associated with Reduced Cancer Risk ... may be at lower risk for developing cancer, especially ... statins directly prevent cancer. , Laboratory studies have shown ... from observational studies has been inconsistent. , To ...
Cached Medicine News:Health News:Procter & Gamble Announces Appointment of Director 2Health News:Shimp Joins Pinstripe as Director of Client Services for Healthcare Group 2Health News:OhioHealth Opens Doors to Next Generation Hospital 2Health News:OhioHealth Opens Doors to Next Generation Hospital 3Health News:OhioHealth Opens Doors to Next Generation Hospital 4Health News:OhioHealth Opens Doors to Next Generation Hospital 5Health News:Torchmark Corporation Announces Fourth Quarter 2007 Earnings Release and Conference Call 2Health News:Other highlights in the Jan. 8 JNCI 2Health News:Other highlights in the Jan. 8 JNCI 3Health News:Other highlights in the Jan. 8 JNCI 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: